Viatris Share Holder Equity 2010-2024 | VTRS

Viatris share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • Viatris share holder equity for the quarter ending September 30, 2024 was $19.792B, a 5.14% decline year-over-year.
  • Viatris share holder equity for 2023 was $20.467B, a 2.87% decline from 2022.
  • Viatris share holder equity for 2022 was $21.072B, a 2.83% increase from 2021.
  • Viatris share holder equity for 2021 was $20.493B, a 10.72% decline from 2020.
Viatris Annual Share Holder Equity
(Millions of US $)
2023 $20,467
2022 $21,072
2021 $20,493
2020 $22,954
2019 $11,884
2018 $12,167
2017 $13,308
2016 $11,118
2015 $9,766
2014 $3,276
2013 $2,960
2012 $3,356
2011 $3,505
2010 $3,615
2009 $3,145
Viatris Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $19,792
2024-06-30 $19,520
2024-03-31 $20,014
2023-12-31 $20,467
2023-09-30 $20,866
2023-06-30 $20,843
2023-03-31 $20,928
2022-12-31 $21,072
2022-09-30 $19,182
2022-06-30 $19,805
2022-03-31 $20,448
2021-12-31 $20,493
2021-09-30 $21,141
2021-06-30 $21,207
2021-03-31 $21,415
2020-12-31 $22,954
2020-09-30 $12,548
2020-06-30 $11,746
2020-03-31 $11,263
2019-12-31 $11,884
2019-09-30 $11,463
2019-06-30 $11,903
2019-03-31 $11,892
2018-12-31 $12,167
2018-09-30 $12,066
2018-06-30 $12,209
2018-03-31 $13,177
2017-12-31 $13,308
2017-09-30 $13,292
2017-06-30 $12,833
2017-03-31 $11,656
2016-12-31 $11,118
2016-09-30 $11,829
2016-06-30 $10,331
2016-03-31 $10,275
2015-12-31 $9,766
2015-09-30 $9,815
2015-06-30 $9,569
2015-03-31 $9,093
2014-12-31 $3,276
2014-09-30 $3,406
2014-06-30 $3,353
2014-03-31 $3,192
2013-12-31 $2,960
2013-09-30 $3,233
2013-06-30 $2,945
2013-03-31 $2,887
2012-12-31 $3,356
2012-09-30 $3,624
2012-06-30 $3,199
2012-03-31 $3,779
2011-12-31 $3,505
2011-09-30 $3,494
2011-06-30 $3,881
2011-03-31 $3,917
2010-12-31 $3,615
2010-09-30 $3,543
2010-06-30 $2,979
2010-03-31 $3,178
2009-12-31 $3,145
2009-09-30 $3,072
2009-06-30 $2,912
2009-03-31 $2,649
Sector Industry Market Cap Revenue
Medical Medical Services $15.576B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00